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Abstract.  
Background. 
Chromophore-containing molecules feature extensively in surgical practice, with 
synthetic dyes gaining popularity over endogenous optical adjuncts. New 
applications for chromophores in diagnostics and operative treatment exploit unique 
chemical structures suited for illuminating target tissues beyond the visual spectrum, 
ranging from ultraviolet (UV) to near-infrared (NIR). This review outlines the rationale 
for surgical chromophore application, the weaknesses and risks in each class of 
these compounds, and areas of foreseeable potential for employment of specialized 
contrast agents. 
Method. 
An English-language literature search applied the following Boolean Search string: 
“dye OR Lake OR Stain OR chromophore” AND “tox$ OR terato* OR carcino$ OR 
Allerg$ OR surg$ OR clinic” using EMBASE, PUBMED, PUBMED central and 
OVIDSp, with back-referencing through Web of KnowledgeTM.  
Results. 
Based on the primary literature, this study proposes a surgically relevant 
classification system of chromophores in current use, which facilitates risk/benefit 
consideration for the surgeon who employs them, and which facilitates clinically 
oriented development. 
Conclusions. 
The next stage of development for optically active surgical adjuncts must address 
practical constraints while minimizing risks of adverse effects. Exploiting the 
technology’s full potential also requires improvements in the usefulness of imagery 
equipment. 
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1. Background 
Optically active surgical adjuncts are widely used in conventional, current surgical 
practice across several specialties, with applications ranging from skin marking ink to 
sentinel lymph node biopsy (SLNB) [1]. The operating surgeon increasingly relies on 
real-time sensory input to guide precise, accurate identification of tissues. Enhanced 
visual differentiation of anatomical structures and diseased tissues becomes 
increasingly important, especially when considering complex, remote or robotized 
surgery [2]. In the conventional operating suite, the surgeon achieves this distinction 
via reflection of overhead white light, which is visible to the naked eye (390-700 nm) 
[3]. Whilst this principle contributes the mainstay of conventional surgery, it suffers 
from several drawbacks including multiple light shadowing, dependence on the 
operating surgeon, and experience [4]. Many bind tightly to circulating amylase, 
thereby being delivered to the intended site (Table 1). Recent literature reports 
considerable effort aimed at enhancing this sensory input through the use of optically 
active surgical adjuncts . However, their current use is based on clinical historical 
precedent, often off-label, and may incur the risk of significant adverse effects. 
Moreover, recent development of surgical techniques using emitted light in the UV 
and NIR spectra merit specific consideration. This review reports a snapshot of 
chromophores in surgical practice, proposes a simple, surgically relevant 
classification, and evaluates current-best evidence regarding their indications, 
adverse effects, contra-indications and salient controversies surrounding their use.  
2. Review Methodology  
Literature was retrieved using the following Boolean Search String: “dye OR Lake 
OR Stain OR chromophore” AND “tox$ OR terato* OR carcino$ OR Allerg$ OR 
surg$ OR clinic”. EMBASE, PUBMED, PUBMED central, and OVIDSp data bases 
were searched for articles in English, published or in press until 31 August 2015. 
Literature was back-referenced using Web of KnowledgeTM software.  
3. Literature review 
3.1 Current clinical deployment 
All visually active entities depend on the presence of an atom or group of atoms in 
the molecule that gives it colour. This moiety is termed the chromophore [5], 
regardless of the classical distinction between dyes, stains mordants and lakes. 
A synopsis of the common chromophore-containing molecules used in current 
surgical practice, and the related specialties in which they continue to be currently 
useful is provided in Table 1.   
3.1.1 Endogenous versus exogenous chromophore-containing molecules   
Endogenous optical adjuncts are typically naturally occurring chromophores, which 
depend on absorption or reflection of light that is then detected unaided by the 
operator. Pathogenic accumulation typically imparts specific optical characteristics to 
tissues and forms the basis of visual differentiation in conventional surgery. This  
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Table 1. Chromophores in current surgical practice, and typical specialties in which their use is 
exploited 
Dye used Reference Uses in current clinical practice studies 
Indigo 
Carmine 
 
 
 
Indocyanine 
Green 
 
Methylene 
Blue 
[6] [7] [8]  
 
 
 
 
 
 
[9] [5] 
Indigo Carmine: Intravenous indigo carmine injection. 
Localize ureteral orifices, severed ureters and fistulous 
communications in radical retropubic prostatectomy and ureteral 
stenosis during robot-assisted ureteroureterostomy. 
 
Indocyanine Green: localization of ureteral stenosis during robot-
assisted ureteroureterostomy.  
 
Methylene Blue: Retrograde vaginal methylene blue testing for 
localization of urinary fistulae openings. Intravesical methylene blue 
identification of the diverticular neck during robot-assisted approach 
for bladder diverticulectomy. 
Bonney’s Blue [10] Bonney's blue: instillation of diluted into the bladder during 
gynecological operation. 
Isosulfan blue [11] Outlining lymphatic channels during surgery thoracic duct ligation. 
Indocyanine 
green 
 
 
Brilliant Blue 
Green 
 
Trypan blue 
 
 
 
Fluorescein 
 
 
 
 
[12] 
 
 
 
 
 
 
[13] 
Indocyanine green: Visualization of lens capsule in cataract 
surgery. Internal limiting membrane (ILM) of the retina green during 
pars plana vitrectomy. 
 
Brilliant Blue Green: Macular hole surgery to stain the ILM. 
 
 
Trypan Blue: Measuring cell viability in-vitro. Visualization of lens 
capsule in cataract surgery. Macular hole surgery to stain the ILM. 
 
 
Visualization of lens capsule in cataract surgery. 
Methylene 
Blue 
[5] 
 
Methylene Blue: stains the parathyroid glands for surgical 
visualization during parathyroidectomy. 
Indocyanine 
green 
[14] Indocyanine Green: Intraoperative blood flow assessment of 
neurovascular system during angiography. 
 
Indocyanine 
green 
 
 
Fluorescein 
 
 
[5] 
 
 
 
 
 
Indocyanine green: ICG angiography is used to objectively quantify 
changes in microcirculation pre- and postoperative skin flap. 
 
Fluorescein: Prediction of breast flaps viability following 
reconstructive surgeries such as radial mastectomy or 
subcutaneous mastectomy. 
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distinction may also be refined by anatomical site (homotopic versus heterotopic), 
rate, and pattern of accumulation. Clinical application of such chromophore-
containing molecules, in diagnosis and to guide operative treatment, still forms the 
core of established medical practice. However, it is also fraught with difficulty, 
including limited sensitivity, specificity and operator dependence. Cutaneous primary 
malignant melanoma is a pertinent example: the number of pigmented lesions that 
need to be excised to diagnose one cutaneous malignant melanoma (numbers 
needed to treat, NNT) is in excess of 8:1, which is operator and experience 
dependent . Even the well-established guidelines for conventional surgical lateral 
margins of excision of primary melanoma are far from satisfactory, having only been 
proven to reduce local recurrence rates (at the cost of significant morbidity) without 
affecting survival rates . The advent of photonic devices such as LASER has 
enabled less collateral damage when compared to conventional surgery [15]. 
However, such techniques still rely on human detection of melanin, and therefore at 
best could be considered as non-inferior treatment modalities.  
3.1.2 Visible versus Ultraviolet and Infrared Applications 
Exogenous optical adjuncts include chromophores not normally present in the 
human body. Whilst most human endogenous chromophore-containing molecules 
are situated within the visible part of the spectrum, synthetic chromophores do not 
suffer from this limitation, and clinically salient examples extend from UV through 
visible to the Infra-Red (IR) spectrum. The use of exogenous chromophore-
containing molecules emitting visible light broadly falls into three categories: 
delineation of anatomical margins; indicators of oncopathogical spread, and as 
miscellaneous therapeutic agents.  
Methylene blue, the first fully synthetic drug introduced in humans, is injected to 
delineate surgical tracks, including fissures, fistulae, sinuses and abscesses [16] and 
as a substitute to Patent Blue V (PBV) for SLNB. Similarly, Bonney’s blue is a 
mixture of gentian (crystal) violet and brilliant green, as an equal parts mixture 
dissolved in ethanol [17]. It is ubiquitously found within operating theatres and is 
used for a plethora of applications, including as a marker for planning surgical 
incision or resection.  Indigo carmine has been used to detect amniotic fluid leakage 
or urine. In the latter application, it is rapidly filtered into urine which it colors blue, 
facilitating detection of urinary leaks [18]. It is important to note that such materials in 
current surgical practice have been in continuous use since that time, and have just 
been accepted on the bases of tradition. Such materials have been in clinical use 
well-before current FDA requirements. 
PBV is a triphenylmethane derivative that is highly visible at small concentrations [5]. 
It is extensively used in lymphatic visualization and SNLB through injection at a 
primary tumor site [5]. However, its sensitivity and specificity are contended. Most 
surgeons use it in combination with a radiolabeled colloid, but its preparation, 
including filtration to limit colloid size, varies widely [5]. A recently launched 
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radiopharmaceutical specifically designed for lymphoscintigraphic intraoperative 
SLNB detection (Tilmanocept) contains multiple diethylene-triamine-penta-acetic acid  
moieties which tightly bind to 99mTc, while its multiple mannose moieties act as 
ligands for multivalent binding to CD 206 mannose receptors on the surfaces of 
reticuloendothelial cells resident in lymph nodes [19]. Whilst PBV is currently still 
considered to be the gold standard for SNLB [20], in two rigorously conducted phase 
III trials, Tilmanocept® correctly identified an additional 20% of melanoma-positive 
sentinel nodes that were not detected by blue dye [21]. PBV is rapidly quenched 
upon exposure to light. Moreover, its color is pH dependent (becoming yellow-
orange in acidic conditions) and reduction-oxidation sensitive (being oxidized to a 
red form in solution). These changes in absorption may potentially explain the 
decreased sensitivity when compared to Tilmanocept.  
Individual chromophore-containing molecules have also found particular niches in 
the treatment of particular conditions. For nearly 100 years, application of methylene 
blue combined with light has been known to have viricidal properties, and has been 
consequently applied in the treatment of Staphylococcus aureus and Hepatitis C . 
High-dose methylene blue has been described as an antidote to cyanide poisoning 
[5].  
UV light ranges in wavelength from 10 to 400 nm, but does not penetrate as deeply 
into human tissues as NIR. Fluorescein angiography (UV) was used for 
intraoperative assessment of microvascular perfusion, but its use was limited by long 
half-life (up to 18 hours for clearance, preventing re-evaluation) and rapid leakage 
into the interstitium, enhanced by local ischemia, leading to false positive results . 
Fluorescein also suffers from a well-documented risk of anaphylaxis-type reactions 
[22]. In contrast, indocyanine green (ICG) is a cyanine class chromophore which is 
visible, but also fluorescent in the NIR range (see Figure 1). IR frequencies penetrate 
deeper than UV, so their use in angiography facilitates imaging deeper patterns of 
circulation than fluorescein angiography. ICG has consequently experienced a wide 
range of novel applications, including measurement of cardiac output, hepatic 
function, and blood flow; as well as ophthalmic angiography . ICG angiography has 
been recently transposed to microvascular surgery by Gurtner and colleagues, its 
short half-life allowing multiple reassessment, as opposed to fluorescein [23]. The 
cyanine also been applied to SLNB .  
However, NIR chromophores themselves are not risk-free. ICG, a well-researched 
chromophore useful in the NIR range, has well-documented and frequently 
overlooked potential adverse effects. In aqueous solution, ICG starts to oligomerize 
when concentrations >3.9 mg/L are reached. This phenomenon leads to non-
applicability of Beer’s Law (the linear relationship between absorbance and 
concentration of an absorbing species), making interpretation difficult [24]. Above 
103 mg/L, ICG forms large aggregates resulting in self quenching, and consequently 
reduced fluorescence, apart from the potential for thrombogenesis [25]. 
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Degeneration in aqueous solution is due to solvent radicals and ions, leading to 
structural loss [26].  
 
 
 
3.2 Applied chemical structure 
In order to understand the risk/benefit imparted by the use of chromophore 
containing molecules, a functional understanding of their common chemical 
structures is important. Each chromophore consists of an arrangement of conjugated 
double bonds, termed a delocalization electron system, and includes a chain of 
methine groups (-CH=) [27]. Electron accepting or donating atoms, such as oxygen 
and nitrogen, are also present at the ends of most colored compounds [25].   
Endogenous chromophores broadly fall into two types: porphyrin-type and melanin 
structures (see Figure 2). The porphyrin ring is central to many naturally occurring 
chromophores including haemoglobin, bilirubin, biliverdin, and cytochromes [5]. It 
also occurs in natural, exogenous chromophores such as the chlorophylls [28]. 
Melanin, in contrast, is produced by the oxidation of the amino acid tyrosine, followed 
by polymerization [5]. This natural chromophore exists in three forms: eumelanin, 
pheomelanin, and neuromelanin [29]. Eumelanin exists in two forms, brown 
eumelanin and black eumelanin. Pheomelanin is a cysteine-containing red polymer 
of benzothiazine units, present in red hair. Finally, neuromelanin is found in the 
central nervous system including the medulla locus coeruleus, the substantia nigra, 
and the zona reticularis of the adrenal gland [5]. Melanin is a frequently employed 
target in conventional LASER therapy [30]. 
Literature presents several complex and overlapping classification systems for 
exogenous chromophore containing molecules [5]. Whilst these systems may be 
exhaustive, they are of limited value to the operative surgeon, as they are based on 
industrial process rather than in vivo use and metabolic fate (see Table 2). In 
contrast, this section briefly discusses the applied significance of common chemical 
structures of chromophores in current surgical use, as part of a simplified, functional 
classification (see Figures 3 & 4).  
3.2.1 Triarylmethane derivatives 
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Triarylmethane is the basic skeleton of this class. Gentian (methyl) violet and brilliant 
green are two examples.  Bonney’s blue is very commonly used as a surgical ink, 
and is composed of brilliant green and gentian violet [31].  
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3.2.2 Triphenylmethane derivatives 
Many members of this class change color with pH, and some even display 
fluorescence. PBV, and its isomer Isosulfan Blue, are members of this class. Within 
the European Union, PBV is authorized as a cosmetic and a food colorant.  
3.2.3 Azo derivatives 
In most azo dyes, the delocalization system includes a benzene or naphthalene 
aromatic ring [32]. A wide range of possible substituent side groups determine the 
color, and many contain more than one azo linkage. Azo dyes could be carcinogenic, 
as a result of their metabolism either in the human body and/or bacterial [33]. 
Reductive cleavage or degradation into component aromatic amines is a typical 
mechanism leading to azo dye mediated genotoxiticy [34]. The hepatic cytochrome 
p-450 isozyme  
Table 2: Definitions of substances containing chromophores in the literature 
Term Definition 
Color additive  Includes any dye, pigment, or other substance that can impart color to a food, 
drug, or cosmetic or to the human body [35]. 
Dye Any substance (natural or synthetic), used to change the color of a target 
[36]. 
Lake  A pigment manufactured by precipitating a dye with an inert binder, or 
"mordant", usually a metallic salt [37]. 
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system in particular is thought to activate mutagenicity of azo dyes, forming a 
mutagenic metabolite/product through N-oxidation [38]. The N-hydroxylaryl amines 
are then either activated (glucuronidation) or inactivated (acetylation), which may 
influence their mutagenicity. In acidic pH, nitrenium ions are formed that can alkylate 
bases in DNA, especially guanine, possibly resulting in carcinogenesis [38].  It 
therefore appears that the products of azo dye metabolism, rather than the parent 
compound itself, are responsible for mutagenesis and subsequent (or perpetuating) 
carcinogenesis. Trypan blue is an example of an azo dye; it is used as a surgical aid 
in ophthalmic surgery . 
3.2.4 Phenothiazine derivatives 
The phenothiazine derivatives are positively-charged chromophore containing 
entities commonly composed of phenol sulphur and nitrogen. Within the three-ring 
chromophore of the thiazine dyes, nitrogen and sulphur make bridges between two 
six-carbon rings [39]. One such example is Methylene blue. 
3.2.5 Cyanine derivatives 
Cyanines are polymethine dyes, which can cover the spectrum from IR to UV. Their 
chemical structure consists of two aromatic rings separated by a polymethine chain.  
ICG is an FDA licensed example which is gaining increasing popularity. Flavonoids 
are naturally occurring cyanines [40]. 
3.2.6 Indigoid derivatives 
Indigo and thioindigo dyes cover the NIR to UV spectrum, depending of their 
chemical composition and structure. These are typically insoluble, colored 
compounds that are solubilized by addition of sulfonate groups to the indigoid 
structure. Indigo carmine is one such example, with its color being both pH and 
reduction-oxidation sensitive. Reports indicate respiratory tract toxicity and 
hypotension as possible side effects [41].  
 
3.3 Adverse effects.  
Literature intensively reports the proposed and purported benefits of optically active 
adjuncts to surgical practice. However, an in-depth discussion of the potential risks 
and adverse effects is notably missing from recent, extensive reviews on the subject 
. It is imperative that the operating surgeon is well-aware of these adverse effects, 
both as ultimate guarantor of patient safety, and due to the risks related to the 
prescription and administration of off-label medicinals [42]. Analysis of the retrieved 
literature regarding chromophores used in current surgical practice reports four 
overarching themes: carcinogenesis, cytotoxicity, metabolic interference, and drug-
drug interactions. 
3.3.1 Carcinogenesis 
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A major concern with chromophore-containing molecules in current surgical practice 
is their carcinogenic potential. The mutagen can either be the chromophore-
containing molecule itself, or its metabolites. In the former category, one finds 
triarylmethane derivatives, whilst azo derivatives feature prominently in the latter 
category.  
Triarylmethane derivative Gentian violet has been associated with mutagenicity, 
carcinogenesis and clastogenicity (induction of chromosomal breaks) in bacterial and 
mammalian cells [43]. Brilliant green is considered to be as toxic as malachite green, 
which is known to be genotoxic and carcinogenic, resulting in its ban from food 
production in the European Union [44]. It has also been demonstrated that PBV, 
methylene blue and indigo carmine, which are commonly used in SNLB, cause DNA 
damage to breast epithelial cells in vitro (MCF-7 and HB-2 cells lines using the 
alkaline comet assay) [45]. Exposure of the methylene blue to ambient light has also 
been reported to cause DNA damage leading to cancer [46]. 
Azo dyes such as trypan blue have been associated to mutagenesis, including basal 
cell carcinoma [47]. Phenylenediamine and benzidine are the major mutagenic 
moieties of carcinogenic azo dyes. Literature shows that only those azo dyes which 
contain either of these molecular moieties possess mutagenic potential (see Section 
3.2, describing azo dye mutagenic pathways). 
3.3.2 Allergy and anaphylaxis  
The occurrence of allergic and anaphylactic reaction following dye administration is 
well-documented. PBV dye is the commonest to be used in SNLB mapping, and it 
has been extensively studied. There is some evidence suggesting anaphylactic 
reactions to PBV are IgE mediated [6]. Based on retrospective studies when 
administered for SNLB, 0.56% patients develop allergic reactions and 0.06% of 
patients develop severe anaphylaxis [48]. However, one prospective study reported 
the overall incidence of allergy associated with PBV dye at 0.9% [49]. The use of 
other substitutes for PBV is not without risk. Methylene blue itself has been 
associated with severe skin necrosis upon intradermal injection, whilst IgE mediated 
anaphylaxis has been demonstrated for isosulfan blue injection [5].  
3.3.3. Cytotoxicity and histotoxicity 
Inhibition of mitochondrial respiration is a major adverse effect that features 
prominently in the critique of triphenylmethane dyes (such as the components of 
Bonney’s blue) [50]. In some countries, its use in food and cosmetics is prohibited . 
In addition, PBV has been found to affect intraoperative pulse oximetric recordings 
[51]. Koivusalo et al report a transient, false lowering of peripheral oxygen saturation 
values immediately after injection of PBV, which has a peak absorption at a 
wavelength of 640 nm. Although the effect is short-lived, arterial oxygen tension 
readings were not affected [52]. Cardio-respiratory arrest due to PBV administration 
has also been reported [5]. Similarly, perilesional injection of isosulfan solution (1%, 
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3 mL) caused a profound pulse oximetry desaturation, whether given sub-areolar, 
intradermal or intraparenchymally .  
Literature also gives some evidence for dye-mediated integumentary toxicity. It has 
been reported that a commercial ink surgical marker pen containing Gentian violet 
causes cell and tissue death and reduced cell migration in tenocytes harvested ex 
vivo from (human) patients undergoing anterior cruciate ligament reconstruction [53]. 
Additionally, at surgically relevant concentrations and exposure times, ICG caused 
acute and chronic retinal pigment epithelium toxicity, whilst trypan blue exhibited 
chronic toxicity at all concentrations tested .   
3.3.4 Drug-drug interactions 
Methylene blue acts as a monoamine oxidase inhibitor, and if infused intravenously 
at doses exceeding 5 mg/kg, it may precipitate serious serotonin toxicity and 
serotonin syndrome, when combined with serotonin reuptake inhibitors (e.g., 
duloxetine, sibutramine, venlafaxine, clomipramine, imipramine). Methylene blue can 
also precipitate haemolytic anaemia in carriers of the G6PD (favism) enzymatic 
deficiency [54]. 
Finally, most of these molecules contain hydrophobic moieties, and are carried in 
complex with albumin. Therefore, the potential for displacement of drugs being 
carried around the body in this way (such as warfarin, and administered hormones 
and steroids) needs to be considered. 
 
4. Rationalized development 
Two broad trends sum up the current research efforts in chromophore-containing 
molecules as surgical adjuncts. The first trend is defined by working on native 
tissues, whilst the second involves the use of extrinsic contrast agents . 
 
4.1 Development based on native tissues 
When activated by energy in the UV-NIR spectrum, neoplastic tissues emit intrinsic 
fluorescence based on unique biochemical and morphological abnormalities. In 
particular, decreased green fluorescence is caused by collagen breakdown, whilst 
red fluorescence is increased due to higher endogenous porphyrin production. Both 
increase the red/green fluorescence ratio and have been reported as predictors of 
malignancy .  
Two-photon fluorescence microscopy is another example which has been studied for 
dynamic imaging of tumor growth and invasion [55]. The potential advantages of this 
technique, compared to one-photon fluorescence techniques, include increased 
depth of penetration and axial resolution [56]. Common drawbacks of this technique 
include the complexity of determining the mechanisms that influence the signal. 
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Moreover, the relationship between the optical signature and disease progression is 
difficult to assess [57].  
Ratios of intrinsic optical absorption of human tissues (water, lipid, blood) compared 
to haemoglobin saturation have been harnessed in NIR spectroscopy for the 
diagnosis and detection of cancer. Applications consist of three-dimensional parallel-
plate diffuse optical tomography and time-domain optical mammography to evaluate 
differentiation between benign and malignant tumors [58]. However, such techniques 
remain significantly limited by practical considerations [59]. 
 
4.2 Extrinsic contrast agents 
Several strides have been recently reported in the use of extrinsic contrast agents. 
Optical imaging with NIR fluorescence relies on a wavelength window (650-900 nm) 
where the tissues present the minimum absorption coefficient, resulting in increased 
tissue penetration. This feature allows the development of probes with high signal to 
background ratios (see Section 3.1 for examples of non-targeted contrast agents).  
The enhanced permeability and retention (EPR) effect is a size-based phenomenon 
whereby large molecules and complexes benefit from enhanced vascular 
permeability and reduced/dysfunctional lymphatic drainage in the peritumoral vicinity 
[60]. Rosenthal et al assert that this effect is principally the result of the expression of 
growth factors that promote vascular permeability [61]. However, an extensive, well-
established body of research clearly demonstrates that this is a Bradykinin-mediated 
effect , with striking similarities between infection and cancer [62]. This concept has 
formed the basis for several commercially successful therapeutics in clinical 
oncology .  
Exploitation of this phenomenon has recently been explored using ICG complexed to 
plasma protein . However, this method relies on complexing of ICG to plasma 
proteins for the size effect, and therefore suffers from the inherent instability of such 
complexes. NIR imaging with ICG complexed to albumin is not helpful in situations 
where there is significant peritumoral inflammation [63].  
The EPR effect is well-established to be a phenomenon of most solid cancer [5]. 
However, complexed ICG does not seem to benefit from this effect, such as in the 
case of renal cell carcinoma [64]. In particular, ICG used in this fashion is susceptible 
to instability in aqueous solution, concentration-dependent aggregation and rapid 
degradation [64]. Therefore, research has focused on increasing stability in biological 
fluids by altering its formulation in poly lactic glutamic acid nanoparticles and 
liposomes, to increase stability and prevent aggregation [65]. Unfortunately, such 
formulations do not alter the potential for toxicity (see Section 3.3).  
 
4.3 Targeted contrast agents 
Non-targeted contrast agents have been extensively explored in the field of cancer, 
yet some tumors present up-regulated proteolytic enzymes, allowing their detection 
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to be correlated with specific characteristics. The notion of targeted products is for  
administration in their inactive state, only to be activated when in contact with a 
localized source of such an enzyme [5]. These techniques present the possibility of 
lower background noise. Commercially available exponents of such technology 
include NIR probes that are activated by proteases, such as cathepsin and matrix 
metalloproteinase [66]. Since cathepsins and matrix metalloproteinases are also 
produced by macrophages and neutrophils, they are also copiously produced in 
inflammatory tissue, rheumatoid arthritis and cerebral ischemia  [5].  
Targeted organic fluorophores exploit the increased metabolism, angiogenesis, 
growth signaling receptors and replicative behavior of tumor cells. NIR fluorescent 
agents conjugate to specific moieties, such as epidermal growth factor receptor, 
Her2/Neu receptor, vascular endothelial growth factor, folate receptors, or 
monoclonal antibodies; providing significantly less background noise whilst 
possessing longer periods of usability when compared to radioactive tracers .  
Intensive research effort has been afforded to the field of quantum dot nanoparticles, 
which are small inorganic crystals of semiconductor materials. Their attractive 
qualities include high signal intensity, size tunability and photo stability [57]. 
However, quantum dots present a significant toxicity hazard, because of their heavy 
metal cores (such as cadmium), their tendency toward aggregation, and stability of 
their surface chemistry [5]. No clinical applications of quantum dots have been 
reported to date. Silica nanoparticles have been presented as a potential 
biocompatible alternative to quantum dots [5]. However, their subcellular distribution, 
prolonged residence in several tissues, and hepatotoxicity in mouse models suggest 
that clinical usefulness is still elusive [67].  
 
5. Future directions 
Several publications in the basic sciences report limited usefulness of conventional 
fluorescence, because of the difficulties caused by non-specific background light and 
absorption of visible light by biological chromophores, limiting depth penetration . In 
contrast, this review reports that such chromophore-containing molecules make up 
the majority of optically active products used in clinical practice. The advantages of 
extra-visible wavelength chromophores have been widely reported, but their 
adoption is also dependent on the development of suitable intra-operative imaging 
systems. Conventional single-band camera systems do not distinguish 
autofluorescence from the probe signal, and they do not compensate for geometric 
and intensity distortions produced by photon-tissue interaction [67]. More recently, 
systems for filtering NIR fluorescence in real time, as well as real-time stereoscopic 
imaging systems combining visible with NIR light, have been described [68]. 
Cost and convenience are practical and important considerations. For example, in 
SLNB, the cost of conventional dye plus radiopharmaceutical techniques, and the 
limited availability of this technology, are often cited as limiting factors [69]. However, 
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NIR techniques are limited by the obligatory requirement for high cost, high 
maintenance equipment [70]. Moreover, the necessity of intraoperative imaging 
systems, whether head-wear or stand-alone, limits operator comfort and tolerance. 
Scope exists for further miniaturization and ergonomic improvement before such 
systems become accepted in the mainstream.  
 
4. Conclusion 
This review appraised the applications of chromophore-containing molecules in 
contemporary operative surgery, including controversies regarding safety and 
efficacy, as well as directions of current research. Advancement of surgery as a 
specialty requires development of techniques that reduce tactile sensory input, as 
well as demanding significantly higher degrees of tissue discrimination than can be 
afforded by the traditional “knife and fork” approach.  
These findings suggest that the research effort in this field is undergoing a “pivot 
shift” toward extrinsic contrast agents (autofluorescence) but away from UV 
emission. However, clinical application of chromophore-containing molecules 
emitting in the extra-visible part of the spectrum is dependent on parallel 
development of appropriate, affordable and convenient detection devices.  
Literature emphasizes the limited usefulness of extrinsic chromophore-containing 
molecules relying on conventional (visible light) fluorescence. We report that such 
chromophore-containing molecules make up the majority of optically active products 
used in clinical practice. The use of most of these agents is based on historical 
precedent, often occurring off-label. Ignorance is no defense at law [71], therefore it 
is imperative that operating surgeons availing themselves of such technology are 
able to appraise the risk involved and share this knowledge in the process of 
informed consent. Widespread availability of agents with dubious characteristics 
suggests that the current surgical community does not perceive this threat to patient 
safety to be actual or significant. 
It is clear that the use of chromophore-containing, optically active surgical adjuncts 
has the potential to significantly improve pathophysiological selectivity towards 
diseased tissue, and consequently, surgical outcomes. Development of cost-
effective, properly trialed, custom-engineered products, rationally tailored toward 
their application is essential for these potential benefits to be translated to clinical 
practice. 
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Figure 1: The electromagnetic spectrum and its relation to visible, ultraviolet and infrared 
light, wavelength, frequency and tissue penetration. EM = electromagnetic; nm = nanometer.  
Figure 2: Chemical structure of (a) porphyrin ring and (b) melanin, illustrating the classical 
electron delocalization system of single and double bonds. 
Figure 3: Chemical structure of commonly used exogenous chromophores. 
Figure 4: The main types of chemical structure for chromophore-containing molecules in 
current clinical use, with examples.  
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